422 related articles for article (PubMed ID: 36149598)
1. Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.
Tyagi R; Vaidya B; Sharma SS
Pharmacol Rep; 2022 Oct; 74(5):790-817. PubMed ID: 36149598
[TBL] [Abstract][Full Text] [Related]
2. Oxylipin transport by lipoprotein particles and its functional implications for cardiometabolic and neurological disorders.
Liang N; Harsch BA; Zhou S; Borkowska A; Shearer GC; Kaddurah-Daouk R; Newman JW; Borkowski K
Prog Lipid Res; 2024 Jan; 93():101265. PubMed ID: 37979798
[TBL] [Abstract][Full Text] [Related]
3. Diabetes drugs and neurological disorders: new views and therapeutic possibilities.
Patrone C; Eriksson O; Lindholm D
Lancet Diabetes Endocrinol; 2014 Mar; 2(3):256-62. PubMed ID: 24622756
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
6. New and emerging regulators of intestinal lipoprotein secretion.
Xiao C; Dash S; Morgantini C; Lewis GF
Atherosclerosis; 2014 Apr; 233(2):608-615. PubMed ID: 24534456
[TBL] [Abstract][Full Text] [Related]
7. The metabolic impact of oral contraceptives.
Krauss RM; Burkman RT
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
[TBL] [Abstract][Full Text] [Related]
8. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis.
Ginsberg HN; Huang LS
J Cardiovasc Risk; 2000 Oct; 7(5):325-31. PubMed ID: 11143762
[TBL] [Abstract][Full Text] [Related]
9. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
Borggreve SE; De Vries R; Dullaart RP
Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes.
Watts GF; Chan DC
Atheroscler Suppl; 2010 Jun; 11(1):61-4. PubMed ID: 20452838
[TBL] [Abstract][Full Text] [Related]
11. [Alzheimer's disease and diabetes - the common pathogenesis].
Halmos T; Suba I
Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
13. Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases.
Blázquez E; Hurtado-Carneiro V; LeBaut-Ayuso Y; Velázquez E; García-García L; Gómez-Oliver F; Ruiz-Albusac JM; Ávila J; Pozo MÁ
Front Endocrinol (Lausanne); 2022; 13():873301. PubMed ID: 35615716
[TBL] [Abstract][Full Text] [Related]
14. Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.
Ghasemi R; Dargahi L; Haeri A; Moosavi M; Mohamed Z; Ahmadiani A
Mol Neurobiol; 2013 Jun; 47(3):1045-65. PubMed ID: 23335160
[TBL] [Abstract][Full Text] [Related]
15. Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders.
Makkar R; Behl T; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Alhazmi HA; Meraya AM
Neurotox Res; 2022 Jun; 40(3):874-883. PubMed ID: 35476315
[TBL] [Abstract][Full Text] [Related]
16. Impact of intermittent fasting on health and disease processes.
Mattson MP; Longo VD; Harvie M
Ageing Res Rev; 2017 Oct; 39():46-58. PubMed ID: 27810402
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
18. Association between insulin resistance and the development of cardiovascular disease.
Ormazabal V; Nair S; Elfeky O; Aguayo C; Salomon C; Zuñiga FA
Cardiovasc Diabetol; 2018 Aug; 17(1):122. PubMed ID: 30170598
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
Watson GS; Craft S
J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
[TBL] [Abstract][Full Text] [Related]
20. The paradox of neuronal insulin action and resistance in the development of aging-associated diseases.
Steculorum SM; Solas M; Brüning JC
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S3-11. PubMed ID: 24529522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
